Computer Motion Announces First-Quarter Results.Business Editors & High-Tech/Health/Medical Writers SANTA BARBARA, Calif.--(BUSINESS WIRE)--April 26, 2000 Computer Motion Inc. (Nasdaq:RBOT RBOT Rotating Bomb Oxidation Test ), the leader in medical robotics, today announced preliminary, unaudited quarterly results for its first quarter ended March 31, 2000. Revenue for the quarter totaled $1.4 million and net loss was $5.0 million. The company anticipates announcing complete financial results for the first quarter on May 5, 2000, and will have a conference call and Webcast at that time. The first-quarter results reflect the difficulty in introducing innovative new technology in a tight capital market. "We were hit with the same decrease in capital spending capital spending Spending for long-term assets such as factories, equipment, machinery, and buildings that permits the production of more goods and services in future years. by health-care providers that many other medical equipment companies faced in this past quarter," said Robert W. Duggan, chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Computer Motion. "Add to that the reluctance in tight budget times to embrace new technology, and our sales force had a very tough time. It is not easy to build something that enhances the quality of life, something that matters to society. Making history usually does not happen overnight. It comes from extraordinary efforts and passion. We are working hard to make our vision a reality." Duggan continued: "Our financial results, although far from satisfactory, are not indicative of the progress and success we achieved in the first quarter. Positive developments included product refinements for increased utility and ease of use; increased market acceptance of our technology; and significant progress in a total procedure solution for effective and repeatable beating heart, endoscopic en·do·scope n. An instrument for examining visually the interior of a bodily canal or a hollow organ such as the colon, bladder, or stomach. en heart bypass surgeries." "We are off to a very strong start in the second quarter," stated Gordon Rogers, chief financial officer of Computer Motion. "We have already booked and/or received purchase orders in excess of $3.5 million in products that are shippable this quarter. These events give us confidence that the second quarter of this year will establish a new all-time record in quarterly revenues. 2000 will be a year of continued growth and progress towards profitability." Computer Motion, the world leader in medical robotics, is creating the cornerstone technologies and products for the Intelligent Operating Room operating room n. Abbr. OR A room equipped for performing surgical operations. (TM). The company develops, manufactures and markets proprietary computer-enhanced and robotic surgical systems, which enhance surgeons' capabilities, improve outcomes and reduce costs. Computer Motion's products include the voice-controlled AESOP Aesop (ē`səp, ē`sŏp), legendary Greek fabulist. According to Herodotus, he was a slave who lived in Samos in the 6th cent. B.C. and eventually was freed by his master. (R) endoscope endoscope, any instrument used to look inside the body. Usually consisting of a fiber-optic tube attached to a viewing device, endoscopes are used to explore and biopsy such areas as the colon and the bronchi of the lungs. positioning system; the HERMES(TM) Control Center, a centralized system that enables the surgeon to voice control a network of "smart" medical devices; and the ZEUS(TM) Robotic Surgical System for new minimally invasive microsurgery microsurgery or micromanipulation Surgical technique for operating on minute structures, with specialized, tiny precision instruments under observation through a microscope, sometimes equipped with cameras to show the operation on a monitor. procedures, such as endoscopic coronary artery bypass grafting (E-CABG(TM)). ZEUS is CE-Marked for commercial sale in the European Community, and the company has completed an FDA-approved Phase 1 Investigational Device Exemption An Investigational Device Exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a Premarket Approval (PMA) application or a Premarket Notification [510(k)] submission to Food and (IDE) study with ZEUS. Computer Motion and Medtronic (NYSE NYSE See: New York Stock Exchange :MDT MDT abbr. Mountain Daylight Time MDT (in the US and Canada) Mountain Daylight Time MDT n abbr (US) (= mountain daylight time) → ) are co-marketing ZEUS. The company's Web site is www.ComputerMotion.com. This news release contains forward-looking statements concerning the company's business and products. Actual results may differ materially depending on a number of risk factors, including the risks of competition and competing technologies; duration or suspension of clinical studies; regulatory clearances and approvals; and physician, hospital and payor acceptance of the company's products. These factors and other risks inherent in the company's business are described from time to time in the company's Securities and Exchange Commission filings, including its Annual Report on Form 10-K. The company undertakes no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion